Correlation Engine 2.0
Clear Search sequence regions


  • foreign (4)
  • insulin (3)
  • metformin (2)
  • mothers (1)
  • patients (2)
  • pregnancy (9)
  • turin (2)
  • women (5)
  • Sizes of these terms reflect their relevance to your search.

    From 2021, PSDTA for women with pregnancy complicated by diabetes will be active in the ASL city of Turin; given the city's increasing multiculturalism, we decided to evaluate from this point of view the patients who entered this pathway. Data on women from 1/10/2022 to 30/09/2023 were collected from the computerized medical record. Total patients: 304, Type of diabetes: T1D 3%; MODY < 1%; T2D 4% Diabetes manifested in pregnancy (DMIP) 2%, GDM 90%, Foreigners prevalence: GDM: 67%, T2D%, T1D: Foreign 11%, Planned vs. neglected pregnancies: GDM 47% vs 18%, T2D 31% vs 32%, DMIP 28% vs 50%, T1D: 66% vs 11%, Therapy: GDM: insulin 31% (multi-injective <30%), metformin 5%, T2D: insulin 100% (multi-injective 68%, metformin in 20%); continuous glycemic sensor in 48%, DMIP: insulin 50% (multi-injective 50%), T1D: multi-injective therapy 33%; pump and glycemic sensor 33%; integrated sensor-micro-infuser system 33%. In the aspect of ISTAT data indicating that for northern Italy, a foreign origin for 26% of mothers, our population is "unbalanced" between GDM, T2D, and DMIP on one side and T1D on the other. The higher percentage of foreigners in the GDM group could be attributable to the higher share of Italian women opting for private practice, conversely, the "missing" share of foreign women with T1D is more difficult to interpret. Unplanned or even neglected pregnancies are significant in women with GDM and DMIP (who are mostly foreign). If these data are confirmed in other Italian realities, corrective strategies need to be planned. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

    Citation

    Francesca Garino, Cristina Gottero, Marcella Balbo, Felicia Visconti, Daniela Sansone, Salvatore Endrio Oleandri. Pregnancy and Diabetes in Turin: Lights and Shadows from Real Life Data. Endocrine, metabolic & immune disorders drug targets. 2024 Jul 26


    PMID: 39069801

    View Full Text